Tower Research Capital (TRC)’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$480 Buy
+297
New +$832 ﹤0.01% 5555
2025
Q1
– Sell
-10
Closed -$323 – 5470
2024
Q4
$323 Hold
10
– – ﹤0.01% 5327
2024
Q3
$179 Hold
10
– – ﹤0.01% 5442
2024
Q2
$218 Hold
10
– – ﹤0.01% 5402
2024
Q1
$353 Hold
10
– – ﹤0.01% 5532
2023
Q4
$315 Hold
10
– – ﹤0.01% 5612
2023
Q3
$159 Buy
10
+7
+233% +$220 ﹤0.01% 5682
2023
Q2
$104 Buy
+3
New +$107 ﹤0.01% 5815
2023
Q1
– Hold
0
– – – 6035
2022
Q4
– Hold
0
– – – 6117
2022
Q3
– Hold
0
– – – 6253
2022
Q2
– Hold
0
– – – 6262
2022
Q1
– Hold
0
– – – 6288
2021
Q4
– Sell
-3
Closed -$1K – 6326
2021
Q3
$1K Buy
+3
New +$889 ﹤0.01% 5486

Other funds holding ICCM

Tower Research Capital (TRC)'s ICCM Position: Q3 2026 in Review

Tower Research Capital (TRC) opened a new position in IceCure Medical (ICCM) in Q3 2026: 297 shares worth $480. The stake represents ﹤0.01% of the portfolio and ranks #5555 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in ICCM as recently as Q4 2024.

Tower Research Capital (TRC) first reported a position in ICCM in Q3 2021 and has held it in 9 quarters since. The position peaked at $1K in Q3 2021. 12 funds tracked by Wall St. Rank hold ICCM as of Q3 2026.

  • Tower Research Capital (TRC) held 297 shares of IceCure Medical worth $480 as of Q3 2026.
  • IceCure Medical was a new Tower Research Capital (TRC) position in Q3 2026.
  • IceCure Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5555 holding.
  • Tower Research Capital (TRC) first reported a position in IceCure Medical in Q3 2021 and has held it in 9 quarters since.
  • Tower Research Capital (TRC)'s IceCure Medical position peaked at $1K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.